Patents by Inventor W. Beau Mitchell

W. Beau Mitchell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170121682
    Abstract: Methods for obtaining purified populations of megakaryocytes and platelets by ex vivo culture of stem cells are provided herein.
    Type: Application
    Filed: January 9, 2017
    Publication date: May 4, 2017
    Inventors: W. Beau Mitchell, Mauro P. Avanzi
  • Patent number: 9574178
    Abstract: Methods for obtaining purified populations of megakaryocytes and platelets by ex vivo culture of stem cells are provided herein.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: February 21, 2017
    Assignee: New York Blood Center, Inc.
    Inventors: W. Beau Mitchell, Mauro P. Avanzi
  • Publication number: 20120238020
    Abstract: Methods for obtaining purified populations of megakaryocytes and platelets by ex vivo culture of stem cells are provided herein.
    Type: Application
    Filed: March 16, 2012
    Publication date: September 20, 2012
    Inventors: W. Beau Mitchell, Mauro P. Avanzi
  • Publication number: 20110160292
    Abstract: Disclosed are methods and compositions for preventing and treating conditions associated with platelet aggregation, comprising administering a therapeutically effective amount of a composition that modifies the interaction of DNAJC10 with ?IIb?3 in a megakaryocyte, thereby altering the expression of ?IIb?3 on the surface of the megakaryocyte.
    Type: Application
    Filed: March 7, 2011
    Publication date: June 30, 2011
    Inventors: W. Beau Mitchell, Mahmoud Yazdani Abyaneh, Amanda Chen
  • Patent number: 7928084
    Abstract: Disclosed are methods and compositions for preventing and treating conditions associated with platelet aggregation, comprising administering a therapeutically effective amount of a composition that modifies the interaction of DNAJC10 with ?IIb?3 in a megakaryocyte, thereby altering the expression of ?IIb?3 on the surface of the megakaryocyte.
    Type: Grant
    Filed: August 19, 2009
    Date of Patent: April 19, 2011
    Assignee: New York Blood Center, Inc.
    Inventors: W. Beau Mitchell, Mahmoud Yazdani Abyaneh, Amanda Chen
  • Publication number: 20100048677
    Abstract: Disclosed are methods and compositions for preventing and treating conditions associated with platelet aggregation, comprising administering a therapeutically effective amount of a composition that modifies the interaction of DNAJC10 with ?IIb?3 in a megakaryocyte, thereby altering the expression of ?IIb?3 on the surface of the megakaryocyte.
    Type: Application
    Filed: August 19, 2009
    Publication date: February 25, 2010
    Inventors: W. Beau Mitchell, Mahmoud Yazdani Abyaneh, Amanda Chen